Earnings History Data for KaloBios Pharmaceuticals (HGEN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

KaloBios Pharmaceuticals

Humanigen, Inc. is a biopharmaceutical company. It focuses on advancing medicines for patients with neglected and rare diseases. The Company's product candidate principally consists of benznidazole, lenzilumab and ifabotuzumab. Humanigen Inc., formerly known as KaloBios Pharmaceuticals Inc., is based in Brisbane, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-05-2022 AH HGEN KaloBios Pharmaceuticals 129.00 -0.32 -0.49 0.00 Humanigen GAAP EPS of -$0.32 beats by $0.14, revenue of $1.04M beats by $0.83M
[5/5/2022 5:49 PM]
2.15 0.31 
(16.58%)
1.81 -0.03 
(-1.63%)
1.67 - 23.53 4,379,602 1,010,000 3,610
12-08-2021 AH HGEN Humanigen, Inc. 1,010 -1.20 -0.46 -0.80 Humanigen EPS misses by $0.37, beats on revenue
[8/12/2021 4:58 PM]
16.99 -0.53 
(-3.03%)
16.80 -0.72 
(-4.11%)
7.50 - 29.20 814,970 990,000 27,793
13-05-2021 AH HGEN Kalobios Pharmaceuticals Inc. 1,085 -1.25 -0.64 0.00 Humanigen EPS misses by $0.61
[5/13/2021 5:10 PM]
17.75 1.02 
(6.10%)
18.10 1.37 
(8.19%)
3.90 - 33.95 1,164,773 1,400,000 84,656
10-03-2021 AH HGEN Humanigen, Inc. 885.50 -0.63 -0.60 0.00 Humanigen EPS beats by $0.04
[3/10/2021 5:22 PM]
15.50 -0.95 
(-5.78%)
16.90 0.45 
(2.74%)
2.25 - 33.95 1,336,318 955,859 17,547